" class="no-js "lang="en-US"> Mark Gergen - Medtech Alert
Thursday, March 30, 2023
Mark Gergen

Mark Gergen

About Mark Gergen

Related Story

Aristea Therapeutics Strengthens its Board of Directors with the Appointment of Three Accomplished Biopharma Leaders From Poseida Therapeutics, Novo Holdings and Pfizer

August 25 2022

Aristea Therapeutics (Aristea), a clinical-stage immunology focused drug development company advancing novel therapies to treat […]